Results 181 to 190 of about 1,940,722 (375)

Cortisol Binding to Proteins in Plasma in the Human Neonate and Infant [PDF]

, 1975
A. J. HADJIAN, M. CHEDIN, C. COCHET, E. M. CHAMBAZ   +3 more
openalex   +1 more source

A Universal Biomimetic Approach for Making Artificial Antigen‐Presenting Cells for T Cell Activation

Advanced Functional Materials, EarlyView.
This study shows a biomimetic silica microcapsule (SMC) fabrication method under mild conditions for making artificial antigen‐presenting cells (aAPCs). Inspired by marine biomineralization, peptide‐mediated biosilicification enables silica shell formation on emulsion templates. The resulting SMCs possess a core–shell structure, controlled fluorescence
Fei Hou, Supun Ranaweera, Xiangke Li, Ruirui Qiao, Yue Hui, Chun‐Xia Zhao   +5 more
wiley   +1 more source

Characteristics of Dolutegravir and Bictegravir Plasma Protein Binding: a First Approach for the Study of Pharmacologic Sanctuaries. [PDF]

Antimicrob Agents Chemother, 2020
Gelé T, Gouget H, Furlan V, Becker PH, Taburet AM, Lambotte O, Barrail-Tran A.   +6 more
europepmc   +1 more source

CLINICAL STUDIES ON ¹³¹I-THYROXINE OR ¹³¹I-TRIIODOTHYRONINE RED CELL PLASMA RATIO AND ¹³¹I-THYROXINE OR ¹³¹I-TRIIODOTHYRONINE BINDING RATE OF PLASMA PROTEIN

, 1964
Kyôju ABE
openalex   +2 more sources

“Therapies Through Gut:” Targeted Drug Delivery for Non‐Gastrointestinal Diseases by Oral Administration

Advanced Healthcare Materials, EarlyView.
Schematic illustration of the mechanism of targeted delivery of nanoparticles including 1) paracellular, 2) endolysosomal escape, 3) receptor mediated endocytosis, and 4) M cell mediated transport for non‐GI diseases by oral administration such as atherosclerosis, cancer, diabetes, and brain diseases. Abstract Oral drug delivery is a promising approach
Subarna Ray, Shehzahdi S. Moonshi, Hang Thu Ta   +2 more
wiley   +1 more source

Studies on Drug Metabolism. V : Binding of Pentobarbital with Plasma Protein (1)

, 1968
Haruo Kitagawa, Hiroyuki Kadosawa, Tetsuya Kamataki, Soichi Yoshida   +3 more
openalex   +2 more sources

Radiation‐Resistant Bacteria Deinococcus radiodurans‐Derived Extracellular Vesicles as Potential Radioprotectors

Advanced Healthcare Materials, EarlyView.
Deinococcus radiodurans‐derived extracellular vesicles (R1‐EVs) provide radioprotection against total‐body irradiation‐induced acute radiation syndrome in mice. R1‐EVs mitigate oxidative damage by scavenging free radicals, promoting intestinal repair, enhancing hematopoietic function, and modulating immune responses. This study highlights the potential
Jeong Moo Han, Godfrey Mwiti, Seo‐Joon Yeom, Jaeyoon Lim, Woo Sik Kim, Sangyong Lim, Seung‐Taik Lim, Eui‐Baek Byun   +7 more
wiley   +1 more source

The Enhancement of Fluorescence and the Decreased Susceptibility to Enzymatic Oxidation of Retinol Complexed with Bovine Serum Albumin, β-Lactoglobulin, and the Retinol-binding Protein of Human Plasma

, 1972
Sidney Futterman, J Heller
openalex   +1 more source

An In Situ Curing, Shear‐Responsive Biomaterial Designed for Durable Embolization of Microvasculature

Advanced Healthcare Materials, EarlyView.
NeoCast is a next‐generation, solvent‐free, non‐adhesive liquid embolic designed for indications where deep occlusion is desired (e.g., tumors and chronic subdural hematoma). This novel agent offers ideal embolic properties: injectability, controllability, excellent visibility, and biocompatibility.
Quynh P. Pham, Jeffrey V. Groom II, Chander Sadasivan, David J. Fiorella, David C. Madoff, Lee‐Jae Guo, Michael Fornaciari, Courtney Guertin, Craig Wiltsey, Lee Core, Jonathan Merlo, William Wustenberg, Renu Virmani, Adam S. Arthur, Robert S. Langer, George M. Whitesides, Upma Sharma   +16 more
wiley   +1 more source

Pharmacokinetics, metabolism, and excretion of [¹⁴C]-valemetostat in healthy male participants, and in vitro plasma protein binding. [PDF]

Cancer Chemother Pharmacol
Tachibana M, Siebers N, Craveiro TV, Kazui M, Ikeda T, Shimizu T, Inaba S, Abutarif MA.   +7 more
europepmc   +1 more source